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Editors: Anton N. Sidawy and Bruce A. PerlerEndovascular repair of ruptured thoracic aortic aneurysms is associated
with high perioperative mortality and morbidity
Philipp Geisbu¨sch, Drosos Kotelis, Tim F. Weber, Alexander Hyhlik-Du¨rr,
Dittmar Bo¨ckler
Purpose: To analyze early and midterm results after endovascular treat-
ment of ruptured thoracic aortic aneurysms (rTAA).
Methods: Between January 1997 and January 2009, a total of 236 patients
received thoracic aortic repair in our institution; 23 patients (14 men;
median age, 75 years; range, 60-88 years) due to a ruptured thoracic aortic
aneurysm (rTAA). Rupture was defined according to computed tomography
angiograpy (CTA) criteria with definite sign for hemorrhage outside the
aortic wall. Patients with symptomatic TAA but with normal CT scans were
excluded. A retrospective analysis of these patients was performed. Median
follow up was 28 months (range, 0.1-82.5 months) and included serial aortic
imaging at discharge, six, and 12 months and annually thereafter.
Results: Technical success rate was 87%. The overall in hospital mortality
was 48% with predominantly (50%) cardiac complications. Neurological
complications occurred in three patients, two patients suffered from a tran-
sient ischemic attack (TIA)/stroke, and one patient experienced paraplegia
after early conversion to open surgery. Primary endoleaks were seen in four
of 25 patients (16%); no secondary endoleak was observed. Early conversion
was necessary in two patients caused by an aortoesophageal fistula. The
one- and three-year survival rates were 37.3% and 29.9% with no aortic or
procedure-related death during follow up. Reintervention was necessary in
four of 25 patients (16%). Cox regression analysis revealed preoperative
renal insufficiency (hazard ratio [HR] 5.85, P = .0073) as an independent
predictor of perioperative death.
Conclusions: The endovascular treatment of ruptured thoracic aortic aneu-
rysms is associated with a high perioperative mortality and morbidity as well
as poor midterm survival. Renal insufficency proved to be an independent
risk factor for perioperative death.Open surgical reconstruction of the internal carotid artery aneurysm at
the base of the skull
Serguei Malikov, Jean Marc Thomassin, Pierre Edouard Magnan, Grigol
Keshelava, Michel Bartoli, Alain Branchereau
Objectives: Aneurysms of the internal carotid artery (ICA) at the base of the
skull are uncommon dangerous lesions whose management remains unclear.
The aim of this retrospective study is to report a standardized surgical tech-
nique of ICA reconstruction with long-term results.
Methods: Between 1988 and 2005, 13 patients (11 men; age 18 to 76 years,
mean 42.6 years) underwent lateral skull base approach with cervical-to-
petrous carotid artery bypass for repair of ICA aneurysms. Principal elements* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00031-6of the technique were: partial resection of the parotid gland without rerout-
ing of the facial nerve; luxation of mandibula; drilling of the bone.
Results: The 13 patients had unilateral aneurysm of the ICA at the base of
the skull. Four aneurysms were of atherosclerotic origin; six fibromuscular
dysplasia; two post-traumatic; one cause was undetermined. The mean
diameter of the aneurysms was 12 mm (range, 7-21 mm). Twelve patients
were symptomatic: six presented neurological events (four strokes, two
transient ischemic attack [TIA]); two retinal events; three compressive
symptoms (two Horner’s syndrome and one paralysis of the glossopharyngeal
nerve); one patient presented a visible pulsatile mass in the neck. One
patient was asymptomatic. There were no post-operative deaths, one TIA,
13 transient palsies of the lower facial nerve, and one transient palsy of
accessory nerve. Palsy of cranial nerves was partial and disappeared within
a mean of 5.6 months (range, 1-10 months). The postoperative angiogram
showed patency in all but one case (one asymptomatic thrombosis). During
follow-up (mean, 152 months), there was one unrelated death, one focal
epileptic seizure, and one controlateral TIA. In November 2008, duplex
showed patency of all 11 grafts (one death, one thrombosis). At 10 years,
the survival, cumulative stroke-free survival, ipsilateral stroke-free, and
patency rates was were 90.9%, 100%, 100%, and 92.3%.
Conclusion: Venous graft bypass from the cervical-to-petrous ICA can be
performed safely with such an approach and produces durable satisfactory
results.A comparative analysis of the outcomes of carotid stenting and carotid
endarterectomy in women
Paola De Rango, Gianbattista Parlani, Valeria Caso, Fabio Verzini, Giuseppe
Giordano, Enrico Cieri, Piergiorgio Cao
Objective: Randomized controlled trials (RCTs) of carotid endarterectomy
(CEA) advised little benefit from surgery in women because of high opera-
tive risk. Whether these findings are also applicable to carotid angioplasty
and stenting (CAS) is subject of investigation. Our aim was to determine
the risk of perioperative and late complications related to CAS and CEA
in women.
Methods: Data from a single-center carotid surgery database including 1065
individuals with CAS (306 women and 759 men) and 1131 with CEA (325
women and 806 men) were analyzed in a consecutive series of patients.
Perioperative risks of death, stroke, and local complications in women
undergoing CAS and CEA were compared. Rates of restenosis >50% and
stroke at 5 years in symptomatic and asymptomatic women were also
assessed.
Results: The perioperative risks of stroke or death were no different in
women who underwent CAS and CEA women (1.9% vs 3.0%; odds ratio [OR]
= 0.63; 95% confidence interval [CI], 0.20-1.7; P = .45) whether they were
symptomatic or not. Other perioperative complications were also similarly
distributed between the two groups of women. Life-table estimates of any
periprocedural stroke/death and ipsilateral stroke at 5 years after the
procedure did not differ between women with CAS and CEA (4.1% vs 8.1%;
Abstracts 247P = .18). Five-year rates of restenosis >50% were nonsignificantly higher in
women after CEA than after CAS (1.8% vs 8.1%; P = .058).
Conclusion: Women with carotid stenosis might have favorable early and
late outcomes from CAS with complication rates similar and even lower than
those attained with CEA. CAS, performed by trained operators, may be
a valid primary choice for treatment of carotid stenosis, particularly in
asymptomatic women for whom the risk of surgery seems to be higher.
However, before claiming CAS for women, these results need to be
confirmed by large RCTs.Analysis of gender-related differences in lower extremity peripheral
arterial disease: 1998-2007
Natalia Egorova, Ageliki G. Vouyouka, Jacquelyn Quin, Stephanie Guillerme,
Alan Moskowitz, Michael Marin, Peter L. Faries
Introduction: Gender-related differences continue to challenge the
management of lower extremity (LE) peripheral arterial disease (PAD) in
women. We analyzed the time-trends in hospital care of such differences.
Methods: Data for patients with PAD from New York, New Jersey, and Flor-
ida state hospital inpatient discharge databases (1998-2007) were analyzed
using univariate and multivariate regression analyses.
Results: The 2.4 million PAD-related inpatient discharge records analyzed
showed a slight decrease of inpatient procedures for both genders.
Compared with men, women had 18% to 27% fewer PAD and 33% to 49% fewer
vascular procedural hospitalizations (P < .0001). They were persistently
more likely than men to be admitted emergently (56% vs 51% in 1998 and
57% vs 53% in 2007) and discharged to a nursing home. During the study
period, the amputation rate declined by 36% in women and 21% in men with
PAD, and similarly, open procedures decreased by 36% and 30%. Endovascu-
lar procedures, however, increased by 150% in women and 144% in men.
Procedural mortality was 4.95% vs 4.37% for men (P < .0001). Female
mortality rates were persistently higher after amputations (9.89 % vs
8.90%, P < .0001), open (5.49% vs 4.00%, P < .0001), and endovascular proce-
dures (2.87% vs 2.10%, P < .0001). Time trends showed improved mortality
for men and women, with a stable difference between the two.
Conclusion: The analysis of representative state administrative databases of
inpatient care records demonstrated improvements in mortality and ampu-
tation rates over time. However, a gender-related disparity in PAD outcomes
remains that merits further investigation.Percutaneous transluminal angioplasty and stenting as first-choice
treatment in patients with chronic mesenteric ischemia
Bram Fioole, Hendrik J.M. van de Rest, Joost R.M. Meijer, Marc van Leersum,
Sebastiaan van Koeverden, Frans L. Moll, Jos C. van den Berg, Jean-Paul P.M.
de Vries
Purpose: Open revascularization in patients with chronic mesenteric
ischemia (CMI) is considered the gold standard. Percutaneous transluminal
angioplasty and stenting (PTAS) is often reserved for patients not suitable
for open revascularization. In our institute, endovascular revascularization
is the first-choice treatment. The purpose of this study was to report the
technical and clinical success rates after endovascular revascularization as
the first-choice treatment in a series of 51 consecutive patients with CMI
at a single tertiary vascular referral center.
Methods: A retrospective review was performed of all consecutive patients
with CMI who underwent PTAS from July 2001 to July 2008. Only symptom-
atic patients treated for atherosclerotic CMI were included. Patency was
evaluated using computed tomography angiography (CTA). Kaplan-Meier
curves were used to calculate patency rates of the treated mesenteric
arteries.
Results: Sixty mesenteric arteries (30 celiac trunks, 24 superior mesenteric,
and 6 inferior mesenteric arteries) were treated in 51 patients (26 men).
Major morbidity was 4%. After dissection of the superior mesenteric artery
(n = 1) and brachial artery (n = 1), respectively, both patients underwent
endarterectomy and patch plasty. In three arteries, the lesion could not
be crossed endovascularly and they were deemed immediate intention-to-
treat failures. The initial technical success rate was 93%. No 30-day
mortality was observed. Median follow-up was 25 months. During follow-
up, 2 patients died from intestinal ischemia. Complete symptom relief wasachieved in 78% of patients. Primary 1- and 2-year patency rates were 86%
 5% and 60%  9%, respectively; primary-assisted patency rates were 88%
 5% and 79%  7%, respectively. During follow-up, 6 patients underwent
open revascularization due to failure of PTAS.
Conclusion: The initial technical success rate of PTAS as first-choice treat-
ment of CMI is >90%. The 2-year primary patency rate dropped to 60%,
but symptomatic in-stent stenoses could often be treated successfully with
renewed endovascular techniques. Including one conversion, 14% of patients
needed open revascularization during follow-up.A single-institution experience with interventions for mesenteric
vasculitis
Yevgeniy Rits, Gustavo S. Oderich, Thomas C. Bower, Dylan V. Miller, Leslie
Cooper, Joseph J. Ricotta II, Manju Kalra, Peter Gloviczki
Objective: This study reviewed the outcomes of open and endovascular
revascularization for mesenteric vasculitis (MV).
Methods: We reviewed the clinical data of all patients who underwent
revascularization for occlusive MV from 1984 to 2008. Patients treated for
aneurysms or mucosal bleeding without ischemic symptoms were excluded.
End points were early mortality and morbidity, survival, freedom from
mesenteric symptoms, and patency. Outcomes of open reconstructions were
compared with the results of 163 patients who underwent open operations
for atherosclerotic disease.
Results: There were 15 patients (13 females, 2 males) with a mean age of
38 years (range, 15-66 years). Etiologies were Takayasu’s arteritis in 7,
polyarteritis nodosa in 4, indeterminate in 3, and giant cell arteritis in
1. The celiac axis was affected in 13, superior mesenteric artery (SMA)
in 13, renal arteries in 8, and the aorta in 4. Seven patients had active
disease, and eight were in remission. Nine (60%) presented with symptom-
atic chronic (n = 8) and acute (n = 1) mesenteric ischemia. Six patients
with asymptomatic disease underwent mesenteric revascularization during
other aortic-based operations. Fourteen patients (93%) had 10 mesenteric
bypasses (8 aortic based; 2 iliac), three had aortoplasties, of which two
had mesenteric patch angioplasties, and one underwent arcuate ligament
release with patch angioplasty. One patient (7%) underwent percutaneous
transluminal angioplasty of SMA stenosis. There were no early deaths. Early
complications occurred in three patients (20%) after open reconstruction,
including gastrointestinal hemorrhage, ileus with re-exploration, and supe-
rior mesenteric vein thrombosis. Median follow-up was 22 months. One
graft thrombosis in a patient with active disease was treated with redo
bypass 74 months after aorta-celiac-SMA bypass. All patients were alive
at 10 years, with similar expected survival compared with the general
population (P = .69). Compared with patients with atherosclerotic disease,
open reconstructions for MV had similar freedom from mesenteric
symptoms (83% vs 75%, P = .80) and similar primary graft patency (83%
vs 84%, P = .9).
Conclusion: Mesenteric vasculitis is a rare manifestation of Takayasu arter-
itis, polyarteritis nodosa, indeterminate, or giant cell arteritis. Open revas-
cularization is durable and effective when needed.Unexpected major role for venous stenting in deep reflux disease
Seshadri Raju, Rikki Darcey, Peter Negle´n
Background: Treatment of chronic venous insufficiency (CVI) has largely
focused on reflux. Minimally-invasive techniques to address superficial and
perforator reflux have evolved, but correction of deep reflux continues to
be challenging. The advent of intravascular ultrasound (IVUS) scan and mini-
mally invasive venous stent technology have renewed interest in the
obstructive component in CVI pathophysiology. The aim of this study is to
assess stent-related and clinical outcomes following treatment by iliac
venous stenting alone in limbs with a combination of iliac vein obstruction
and deep venous reflux.
Methods: A total of 528 limbs in 504 patients, ranging in age from 15 to 87,
underwent IVUS-guided iliac vein stent placement to correct obstruction
over an 11-year period. The etiology of obstruction was nonthrombotic in
196 (37%), post-thrombotic in 285 (54%) limbs, and combined in 47 (9%). Clin-
ical severity class of CEAP was C3 in 44%, C4,5 in 27%, and C6 in 25% of
stented limbs. Deep venous reflux was present in all limbs, associated with
248 Abstractssuperficial and/or perforator reflux in 69%. Reflux was severe in 309/528
(59%) limbs (reflux multisegment score 3) and 224/528 (42%) limbs had
axial reflux. Venography and other functional tests had poor diagnostic
sensitivity to detect obstruction, which was ultimately diagnosed by IVUS.
The IVUS-guided iliac vein stenting was the only procedure performed and
the associated reflux was left uncorrected.
Results: There was no mortality; morbidity was minor. Cumulative
secondary stent patency was 88% at 5 years; no stent occlusions occurred
in nonthrombotic limbs. Cumulative rates of limbs with healed active ulcers,
freedom of ulcer recurrence in legs with healed ulcers (C5), and freedom
from leg dermatitis at 5 years were 54%, 88%, and 81%, respectively. Cumu-
lative rate of substantial improvement of pain and swelling at 5 years was
78% and 55%, respectively. Quality of life improved significantly. Reflux
parameters did not deteriorate after stenting.
Conclusion: Iliac venous stenting alone is sufficient to control symptoms in
the majority of patients with combined outflow obstruction and deep re-
flux. Partial correction of the pathophysiology in limbs with multisystem
or multilevel disease can provide substantial symptom relief. Percutaneous
stent technology in concert with other minimally-invasive techniques to
address superficial and/or perforator reflux offers such partial correction
in limbs with advanced CVI and complex venous pathology. Open correction
of obstruction or reflux is now required only infrequently as a ‘‘last
resort’’.Management of diabetic foot problems
Jeffrey Kalish, Allen Hamdan
Background: Diabetic foot problems and their complications are a medical
and economic challenge to the health care system and require an aggressive
multidisciplinary approach to achieve limb salvage. The goals of this review
article are to delve into this comprehensive topic and summarize key points
regarding diabetic foot problems from the perspective of the vascular
specialist treating these patients.
Methods: The MEDLINE database was searched to identify articles on this
topic.
Results: We found 112 relevant articles. These were used to provide current
data on (1) the pathogenesis leading to diabetic foot lesions (ie, the etiologic
triad of ischemia, neuropathy, and infection), (2) the clinical presentation of
these foot lesions and their systemic manifestations, (3) the optimal
methods of diagnostic evaluation, including noninvasive testing and arteriog-
raphy, (4) treatment selection guidelines to help delineate which patients
require revascularization, and (5) medical and interventional treatments,
including prevention strategies, wound healing strategies, use of antibiotics,
and endovascular and open surgical options for revascularization.
Conclusions: The data presented in this review article allow vascular clini-
cians to optimize patient care and achieve effective limb salvage for this
growing segment of the population.
